Rinsho Ketsueki
Online ISSN : 1882-0824
Print ISSN : 0485-1439
ISSN-L : 0485-1439
Clinical Study on Chemotherapy for Multiple Myeloma
Part II: Prognostic Factors of Treatment with Prednisolone and Sequential Melphalan and Ifosfamide: MIP Therapy
Tatsuo SEZAKIHirofumi ISHIITomiroh ADACHIIsao TAKAHASHITaisuke OHNOSHIIkuro KIMURA
Author information
JOURNAL RESTRICTED ACCESS

1983 Volume 24 Issue 4 Pages 433-439

Details
Abstract

The effect of certain disease parameters on response rate and survival time was evaluated in 47 patients with multiple myeloma treated with MIP therapy.
The results as follow:
1) In the response rate, older than 70 years old, female and poor risk factors such as anemia, hypercalcemia and hypoalbuminemia were associated with high response rates. IgA myeloma also showed higher response rate, in comparison with IgG myeloma.
2) In the survival time, older than 70 years old, male and poor risk factors such as hypoalbuminemia, elevated M-protein, hypercalcemia and extensive boone lesion were associated with short survival times. In addition, advanced stage showed significantly short survival times.
3) Greater degrees of M-protein reduction from chemotherapy were associated with longer survival times. Patiens in whom a marked M-protein reduction was rapid had longer remission and survival times than patients more slowly.
4) In the types of morphological myeloma proliferation, high respons rate on tumor forming type and long survival time on diffus proliferative type were obviously observed.

Content from these authors
© 1983 The Japanese Society of Clinical Hematology
Previous article Next article
feedback
Top